[Susceptibility to antibiotics of some species of Enterobacter isolated from various clinical materials].
We investigated 185 strains of Enterobacter spp. (E. cloacae--143 strains, E. agglomerans--15 strains, E. sakazakii--14 strains and E. aerogenes--13 strains) isolated from several clinical materials. An agar diffusion assay on Mueller-Hinton Agar was performed (according to NCCLS procedure and National Reference Center of Microorganisms' Drug-sensitiveness at Central Laboratory of Sera and Vaccinations in Warsaw Poland). E. cloacae: about 90% of the strains were sensitive to carbapenems. 85.3% of the isolates were susceptible to piperacillin + tazobactam. About 80% of the strains were susceptible to cotrimoxazole and ciprofloxacin. E. agglomerans: all strains were susceptible to imipenem, and 86.7%--to meropenem. 86.7% of the strains were susceptible to ureidopenicillins + inhibitors of beta-lactamases. About 80% of the isolates were susceptible to cotrimoxazole and ciprofloxacin. E. sakazakii: all isolates were susceptible to carbapenems. About 90% of the strains were susceptible to cotrimoxazole and 50%--to ciprofloxacin. E. aerogenes: all of the strains were susceptible to carbapenems and ciprofloxacin, 92.3%--to cotrimoxazole.
Janicka
G
G
Katedry i Zakładu Mikrobiologii Akademii Medycznej w Bydgoszczy.
Kania
I
I
Kłyszejko
C
C
Wróblewski
M
M
Ulatowska
B
B
D004352:Drug Resistance, Microbial; D004754:Enterobacter / Q000145:classification / Q000187:drug effects*; D006801:Humans; D008826:Microbial Sensitivity Tests; D013045:Species Specificity